We turn our projects into products by closing collaborative agreements with Universities,Hospitals, Dutch SME's(Mkb ),Flemish Institutions and Universities located in North-Holland, South-Holland,Brabant,Limburg, Gelderland and Flanders
30 investigational new molecular entities are registered at iDEPOT for chemical synthesis and testing in bioassays We have a location in Flanders that supports our operations in the Flemish region ( VLAIO)
BeneluxBio BV is a company that develops new drugs for brain diseases and neurological disorders. Its current projects focus on epilepsy, glioblastoma, primary central nervous system lymphoma (PCNSL), and post-neurosurgical CRE meningitis and ventriculitis. CRE stands for carbapenem-resistant Enterobacteriaceae. We use proprietary lead compounds. We are a pharmaceutical research and development company and not a services company.
European Innovation programme South Netherlands
With support from the European Union Medegefinancierd door de Europese Unie
Discovered, developed and produced in the Benelux